Terms ending in 2032
Every in-force patent on Acclarent, Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,534,192 | Methods and Apparatus for Treating Disorders of the Sinuses In force · High confidence | Acclarent, Inc. | In force | High confidence | |
| US 8,485,199 | Methods and devices for Protecting Nasal Turbinate During Surgery In force · High confidence | Acclarent Inc., a Delaware Corporation | In force | High confidence | |
| US 9,095,646 | Devices and Methods for Transnasal Dilation and Irrigation of the Sinuses In force · High confidence | Acclarent, Inc. | In force | High confidence | |
| US 10,806,849 | Devices and Methods for Transnasal Irrigation or Suctioning of the Sinuses In force · High confidence | Acclarent, Inc. | In force | High confidence | |
| US 10,195,369 | Personalizable System and Method for Anesthetizing the Tympanic Membrane In force · High confidence | Tusker Medical, Inc. | In force | High confidence | |
| US 11,045,614 | Personalizable System and Method for Anesthetizing the Tympanic Membrane In force · High confidence | Tusker Medical, Inc. | In force | High confidence | |
| US 9,387,124 | Disposable Iontophoresis System and Tympanic Membrane Pain Inhibition Method In force · High confidence | Tusker Medical, Inc. | In force | High confidence | |
| US 9,078,783 | Silent Effusion Removal In force · High confidence | Acclarent, Inc. | In force | High confidence |
8 of 8 patents shown. Soonest term end first, then patent number.
5 of these are in force and held by Acclarent, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.